2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide

Catalog No.: 
ACXTSO386
CAS No.: 
936-16-3
Molecular Formula: 
C7H7NO2S
Molecular Weight: 
169.21
2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$108.00In stockIn stock
5g96%$440.00In stockIn stock
25g96%$1760.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide
IUPAC Name2,3-dihydrobenzo[d]isothiazole 1,1-dioxide
MDL No.MFCD03426201
Molecular FormulaC7H7NO2S
Molecular Weight169.21
SMILESO=S1(NCC2=CC=CC=C21)=O
InChI KeyGVYVHZKTSVDMNT-UHFFFAOYSA-N
Synonym2,3-dihydro-1lambda6,2-benzothiazole-1,1-dione;2,3-DIHYDRO-1,1-DIOXO-1,2-BENZISOTHIAZOLE;1,2-benzoisothiazoline 1,1-dioxide;2,3-dihydro-1,2-benzothiazole 1,1-dioxide;2,3-dihydro-1,2-benzisothiazole 1,1-dioxide;2,3-Dihydrobenzo[d]isothiazole 1,1-dioxide;1,2-Benzisothiazole, 2,3-dihydro-, 1,1-dioxide
CAS No.936-16-3
PubChem CID13638

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACXTSO386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACHDPL041 route compound structure diagram
    ACHDPL04182385-42-0In Stock
  2. Then
  3. ACXTSO386 route product structure diagram
    ACXTSO386936-16-3In Stock
Inquiry

2. ACXTSO386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXTSO386 route product structure diagram
    ACXTSO386936-16-3In Stock
Inquiry

3. ACXTSO386 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACXTSO386 route product structure diagram
    ACXTSO386936-16-3In Stock
Inquiry

Comments (0)